Home Cart 0 Sign in  

[ CAS No. 1395084-25-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 1395084-25-9
Chemical Structure| 1395084-25-9
Structure of 1395084-25-9 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 1395084-25-9 ]

Related Doc. of [ 1395084-25-9 ]

Alternatived Products of [ 1395084-25-9 ]

Product Details of [ 1395084-25-9 ]

CAS No. :1395084-25-9 MDL No. :MFCD27992062
Formula : C18H17N5O3S Boiling Point : -
Linear Structure Formula :- InChI Key :DZTGIRNXWSZBIM-UHFFFAOYSA-N
M.W : 383.42 Pubchem ID :135566899
Synonyms :
Chemical Name :(E)-4-((2-Amino-4-hydroxy-5-methylphenyl)diazenyl)-N-(pyridin-2-yl)benzenesulfonamide

Calculated chemistry of [ 1395084-25-9 ]

Physicochemical Properties

Num. heavy atoms : 27
Num. arom. heavy atoms : 18
Fraction Csp3 : 0.06
Num. rotatable bonds : 5
Num. H-bond acceptors : 6.0
Num. H-bond donors : 3.0
Molar Refractivity : 103.36
TPSA : 138.41 Ų

Pharmacokinetics

GI absorption : Low
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : Yes
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.64 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.75
Log Po/w (XLOGP3) : 2.81
Log Po/w (WLOGP) : 4.79
Log Po/w (MLOGP) : 0.83
Log Po/w (SILICOS-IT) : 2.02
Consensus Log Po/w : 2.44

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 1.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -4.15
Solubility : 0.0271 mg/ml ; 0.0000707 mol/l
Class : Moderately soluble
Log S (Ali) : -5.37
Solubility : 0.00162 mg/ml ; 0.00000423 mol/l
Class : Moderately soluble
Log S (SILICOS-IT) : -6.52
Solubility : 0.000115 mg/ml ; 0.000000301 mol/l
Class : Poorly soluble

Medicinal Chemistry

PAINS : 1.0 alert
Brenk : 2.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 3.22

Safety of [ 1395084-25-9 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 1395084-25-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 1395084-25-9 ]

[ 1395084-25-9 ] Synthesis Path-Upstream   1~5

  • 1
  • [ 144-83-2 ]
  • [ 2835-95-2 ]
  • [ 1395084-25-9 ]
YieldReaction ConditionsOperation in experiment
14%
Stage #1: With hydrogenchloride In methanol; water; acetonitrile at -2 - 0℃; for 0.0833333 h;
Stage #2: With isopentyl nitrite In methanol; water; acetonitrile at 0℃; for 0.166667 h; Inert atmosphere
Stage #3: With potassium carbonate In methanol; water; acetonitrile at 0 - 5℃; for 1.25 h; Inert atmosphere
B. Synthesis ofTarget-7: MS0129436To a stirred solution of amine (12 g, 0.048 lmol) in methanol and ACN (1 : 1, 240 mL) was added cone. HC1 (20.4 mL) and stirred at 0 °C to -2 °C for 5 min. Then isoamyl nitrite (6.48mL, 0.553 mol) was added dropwise for 10 min under inert atmosphere and the reaction mixture was stirred at 0°C for 45 min. Meanwhile homogenous solution of 5- aminocresol (5.92 g, 0.0481 mol) and potassium carbonate (33.2 g, 0.24067 mol) in water (500 mL) was prepared. This solution was de-gassed by purging N2 for 15 min and then was added via cannula to the previously prepared diazonium salt solution at 0-5°C and the resulting reaction mixture was stirred at 0-5°C for 1 h. The reaction mixture was then acidified with 1 N HC1 (pH = 6) and the reaction was filtered. Fitrate was extracted with EtOAc (2 x 300mL) and the solid ppt was stirred in isopropyl alcohol for 3 h at room temperature and filtered. The combined organic extracts were distilled under reduced pressure to obtain orange-red crude residue. The solid was purified by columnchromatography (twice) using methanol/DCM to afford target 7 (2.6g, 14percent yield).TLC: 5percent MeOH/DCM, Rf: 0.5)HPLC purity: 98.63percent, IP 10041325Melting point: 217.2°CMass: 383 (M+l) 1HNMR (500MHz, DMSOd6) 5:9.22 (bs, 1H), 8.0(m, 3H), 7.9(d, 2H), 7.72(t, 1H), 7.54 (s, 2H), 7.2 (d, 1H), 6.8 (t, 1H), 2.21 (s, 6H).
Reference: [1] Patent: WO2012/116170, 2012, A1, . Location in patent: Page/Page column 68-69
[2] Journal of Medicinal Chemistry, 2013, vol. 56, # 22, p. 9251 - 9264
  • 2
  • [ 19077-98-6 ]
  • [ 1395084-25-9 ]
Reference: [1] Journal of Medicinal Chemistry, 2013, vol. 56, # 22, p. 9251 - 9264
  • 3
  • [ 98-74-8 ]
  • [ 1395084-25-9 ]
Reference: [1] Journal of Medicinal Chemistry, 2013, vol. 56, # 22, p. 9251 - 9264
  • 4
  • [ 504-29-0 ]
  • [ 1395084-25-9 ]
Reference: [1] Journal of Medicinal Chemistry, 2013, vol. 56, # 22, p. 9251 - 9264
  • 5
  • [ 1028-11-1 ]
  • [ 1395084-25-9 ]
Reference: [1] Journal of Medicinal Chemistry, 2013, vol. 56, # 22, p. 9251 - 9264
Same Skeleton Products
Historical Records